This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1995 Nov 17;270(5239):1219; author reply 1220-2.

Attenuated retrovirus vaccines and AIDS

H W Kestler, K T Jeang

PMID: 7502052

Comment

Attenuated retrovirus vaccines and AIDS

H W Kestler et al. Science. 1995.

. 1995 Nov 17;270(5239):1219; author reply 1220-2.

Authors

H W Kestler, K T Jeang

PMID: 7502052

No abstract available

PubMed Disclaimer

Comment on

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
Baba TW, Jeong YS, Pennick D, Bronson R, Greene MF, Ruprecht RM. Baba TW, et al. Science. 1995 Mar 24;267(5205):1820-5. doi: 10.1126/science.7892606. Science. 1995. PMID: 7892606

Similar articles

Attenuated HIV vaccine: caveats.
Ruprecht RM, Baba TW, Liska V. Ruprecht RM, et al. Science. 1996 Mar 29;271(5257):1790-2. Science. 1996. PMID: 8596941 No abstract available.
A conditionally replicating virus as a novel approach toward an HIV vaccine.
Das AT, Verhoef K, Berkhout B. Das AT, et al. Methods Enzymol. 2004;388:359-79. doi: 10.1016/S0076-6879(04)88028-5. Methods Enzymol. 2004. PMID: 15289083 No abstract available.
Naturally attenuated HIV--lessons for AIDS vaccines and treatment.
Collins KL, Nabel GJ. Collins KL, et al. N Engl J Med. 1999 Jun 3;340(22):1756-7. doi: 10.1056/NEJM199906033402210. N Engl J Med. 1999. PMID: 10352170 No abstract available.
1999: a time to re-evaluate AIDS vaccine strategies.
Ruprecht RM, Hofmann-Lehmann R, Rasmussen RA, Vlasak J, Xu W. Ruprecht RM, et al. J Hum Virol. 2000 Mar-Apr;3(2):88-93. J Hum Virol. 2000. PMID: 10850895 Review.
Relative importance and functional role of genetic elements targeted for a live attenuated AIDS vaccine.
Lang SM, Desrosiers RC. Lang SM, et al. Antibiot Chemother (1971). 1996;48:92-9. doi: 10.1159/000425162. Antibiot Chemother (1971). 1996. PMID: 8726510 Review. No abstract available.

See all similar articles

Cited by

Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251.
Shacklett BL, Shaw KE, Adamson LA, Wilkens DT, Cox CA, Montefiori DC, Gardner MB, Sonigo P, Luciw PA. Shacklett BL, et al. J Virol. 2002 Nov;76(22):11365-78. doi: 10.1128/jvi.76.22.11365-11378.2002. J Virol. 2002. PMID: 12388697 Free PMC article.
Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection.
Venzke S, Michel N, Allespach I, Fackler OT, Keppler OT. Venzke S, et al. J Virol. 2006 Nov;80(22):11141-52. doi: 10.1128/JVI.01556-06. Epub 2006 Aug 23. J Virol. 2006. PMID: 16928758 Free PMC article.
A candidate live inactivatable attenuated vaccine for AIDS.
Chakrabarti BK, Maitra RK, Ma XZ, Kestler HW. Chakrabarti BK, et al. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9810-5. doi: 10.1073/pnas.93.18.9810. Proc Natl Acad Sci U S A. 1996. PMID: 8790413 Free PMC article.
Association with PAK2 Enables Functional Interactions of Lentiviral Nef Proteins with the Exocyst Complex.
Imle A, Abraham L, Tsopoulidis N, Hoflack B, Saksela K, Fackler OT. Imle A, et al. mBio. 2015 Sep 8;6(5):e01309-15. doi: 10.1128/mBio.01309-15. mBio. 2015. PMID: 26350970 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.